Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-156981
Filing Date
2016-11-14
Accepted
2016-11-14 17:30:32
Documents
83
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17154_110q.htm 10-Q 788776
2 EX-31.1 a16-17154_1ex31d1.htm EX-31.1 10675
3 EX-31.2 a16-17154_1ex31d2.htm EX-31.2 10482
4 EX-32.1 a16-17154_1ex32d1.htm EX-32.1 5769
5 EX-32.2 a16-17154_1ex32d2.htm EX-32.2 6143
  Complete submission text file 0001104659-16-156981.txt   5008192

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20160930.xml EX-101.INS 950619
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20160930.xsd EX-101.SCH 68136
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20160930_cal.xml EX-101.CAL 41157
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20160930_def.xml EX-101.DEF 230708
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20160930_lab.xml EX-101.LAB 482134
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20160930_pre.xml EX-101.PRE 410032
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 161996161
SIC: 2834 Pharmaceutical Preparations